|
Volumn 60, Issue 20, 2000, Pages 5599-5602
|
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats
a b c c c b b a c |
Author keywords
[No Author keywords available]
|
Indexed keywords
CELECOXIB;
CYCLOOXYGENASE 2 INHIBITOR;
N BUTYL N (4 HYDROXYBUTYL)NITROSAMINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
BLADDER CARCINOMA;
CANCER GROWTH;
CANCER SURVIVAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
FEMALE;
MALE;
MOUSE;
NONHUMAN;
PRECANCER;
PRIORITY JOURNAL;
RAT;
SQUAMOUS CELL CARCINOMA;
TRANSITIONAL CELL CARCINOMA;
ANIMALS;
ANTICARCINOGENIC AGENTS;
BUTYLHYDROXYBUTYLNITROSAMINE;
CARCINOGENS;
CARCINOMA, SQUAMOUS CELL;
CARCINOMA, TRANSITIONAL CELL;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DISEASE MODELS, ANIMAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
ISOENZYMES;
MALE;
MICE;
MICE, INBRED C57BL;
MICE, INBRED DBA;
ORGAN SPECIFICITY;
PRECANCEROUS CONDITIONS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PYRAZOLES;
RATS;
RATS, INBRED F344;
SULFONAMIDES;
URINARY BLADDER NEOPLASMS;
|
EID: 0034667354
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (258)
|
References (27)
|